WallStreetZenWallStreetZen

NASDAQ: ERNA
Eterna Therapeutics Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

ERNA past revenue growth

How has ERNA's revenue growth performed historically?
Company
N/A
Industry
148.64%
Market
17.33%
ERNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ERNA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ERNA earnings and revenue history

Current Revenue
$68.0k
Current Earnings
-$21.7M
Current Profit Margin
-31,888.2%

ERNA Return on Equity

Current Company
-509%
Current Industry
-63.5%
Current Market
188%
ERNA's Return on Equity (-509%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ERNA announces earnings.

ERNA Return on Assets

Current Company
-53.1%
Current Industry
2.9%
ERNA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ERNA Return on Capital Employed

Current Company
-49.48%
Current Industry
19.5%
ERNA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ERNA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ERNA$68.00k-$19.93M-$21.68M-68.89%N/A
GRTX$0.00-$47.41M-$59.08MN/AN/A
BNOX$14.50kN/A-$20.40M-91.52%+261.25%
KZIA$15.13kN/A-$10.33M-65.97%N/A
ELAB$1.71M-$4.27M-$4.30M+4,450.66%N/A
View Top Biotech Stocks

ERNA earnings dates

Next earnings date
May 6, 2024

Eterna Therapeutics Earnings & Revenue FAQ

What were ERNA's earnings last quarter?

On Invalid Date, Eterna Therapeutics (NASDAQ: ERNA) reported Q4 2023 earnings per share (EPS) of -$1.14, up 11.76% year over year. Total Eterna Therapeutics earnings for the quarter were -$6.16 million. In the same quarter last year, Eterna Therapeutics's earnings per share (EPS) was -$1.02.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.

What was ERNA's earnings growth in the past year?

As of Q2 2024, Eterna Therapeutics's earnings has grown year over year. Eterna Therapeutics's earnings in the past year totalled -$21.68 million.

What is ERNA's earnings date?

Eterna Therapeutics's earnings date is Invalid Date. Add ERNA to your watchlist to be reminded of ERNA's next earnings announcement.

What was ERNA's revenue last quarter?

On Invalid Date, Eterna Therapeutics (NASDAQ: ERNA) reported Q4 2023 revenue of $17.00 thousand up Infinity% year over year. In the same quarter last year, Eterna Therapeutics's revenue was $0.00.

What was ERNA's revenue growth in the past year?

As of Q2 2024, Eterna Therapeutics's revenue has grown null year over year. Eterna Therapeutics's revenue in the past year totalled $68.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.